416 related articles for article (PubMed ID: 27764780)
21. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
Wilczyński JR; Nowak M
Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
[TBL] [Abstract][Full Text] [Related]
22. Cancer immunotherapy: accomplishments to date and future promise.
Helmy KY; Patel SA; Nahas GR; Rameshwar P
Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
[TBL] [Abstract][Full Text] [Related]
23. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
24. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
25. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
26. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic applications of the cancer immunoediting hypothesis.
Desai R; Coxon AT; Dunn GP
Semin Cancer Biol; 2022 Jan; 78():63-77. PubMed ID: 33711414
[TBL] [Abstract][Full Text] [Related]
28. Expression of tumour-specific antigens underlies cancer immunoediting.
DuPage M; Mazumdar C; Schmidt LM; Cheung AF; Jacks T
Nature; 2012 Feb; 482(7385):405-9. PubMed ID: 22318517
[TBL] [Abstract][Full Text] [Related]
29. [Escape Strategies of Tumors from Immune Surveillence].
Šťastný M; Říhová B
Klin Onkol; 2015; 28 Suppl 4():4S28-37. PubMed ID: 26647886
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.
Hwang I; Nguyen N
Arch Pharm Res; 2015 Aug; 38(8):1415-33. PubMed ID: 25634101
[TBL] [Abstract][Full Text] [Related]
31. MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
Ward PL; Schreiber H
Semin Cancer Biol; 1991 Oct; 2(5):321-8. PubMed ID: 1837738
[TBL] [Abstract][Full Text] [Related]
32. Tolerance and immune suppression in the tumor microenvironment.
Ostrand-Rosenberg S
Cell Immunol; 2016 Jan; 299():23-9. PubMed ID: 26435343
[TBL] [Abstract][Full Text] [Related]
33. Escape from immune- and nonimmune-mediated tumor surveillance.
Malmberg KJ; Ljunggren HG
Semin Cancer Biol; 2006 Feb; 16(1):16-31. PubMed ID: 16140546
[TBL] [Abstract][Full Text] [Related]
34. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle-based immunotherapy for cancer.
Shao K; Singha S; Clemente-Casares X; Tsai S; Yang Y; Santamaria P
ACS Nano; 2015 Jan; 9(1):16-30. PubMed ID: 25469470
[TBL] [Abstract][Full Text] [Related]
36. Immunoepigenetics: the unseen side of cancer immunoediting.
Germenis AE; Karanikas V
Immunol Cell Biol; 2007 Jan; 85(1):55-9. PubMed ID: 17130900
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.
Seliger B
HLA; 2016 Nov; 88(5):213-220. PubMed ID: 27659281
[TBL] [Abstract][Full Text] [Related]
38. Scientific contributions toward successful cancer immunotherapy in The Netherlands.
Melief CJ; Scheper RJ; de Vries IJ
Immunol Lett; 2014 Dec; 162(2 Pt B):121-6. PubMed ID: 25455598
[TBL] [Abstract][Full Text] [Related]
39. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
Stewart TJ; Smyth MJ
Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
[TBL] [Abstract][Full Text] [Related]
40. [The interplay of immunotherapy and chemotherapy, a novel approach].
Hanoteau A; Henin C; Moser M
Med Sci (Paris); 2016 Apr; 32(4):353-61. PubMed ID: 27137692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
